Data / Drug companies / Inactivated Japanese Encephalitis Virus Vaccine
Inactivated Japanese Encephalitis Virus Vaccine drugs: 1 drug from 3 companies in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Inactivated Japanese Encephalitis Virus Vaccine is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 4 products in this class from 3 companies, covering 1 drug by generic name. The main marketing category is unapproved homeopathic products, and the newest product started marketing on March 30, 2009.
The request: Get every company that lists a Inactivated Japanese Encephalitis Virus Vaccine drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 3Companies
- 4Products
- 1Drugs by generic name
Drugs in the Inactivated Japanese Encephalitis Virus Vaccine class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Japanese encephalitis vaccine, inactivated, adsorbed | 2 | 2 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Professional Complementary Health Formulas | 2 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Valneva Scotland Ltd. | 1 | injection, suspension | Biologics (BLA) | March 30, 2009 |
| Vetter Pharma Fertigung GmbH & Co. KG | 1 | injection, suspension | Biologics (BLA) | March 30, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 2 | 50% |
| Injection, suspension | 2 | 50% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.